The literature supports consistent changes in ApoB, Sod2, and EML4 trends with the results of this study, confirming a potential relationship between the therapeutic effects of SA on preeclampsia and the PI3K/Akt/eNOS pathway. This evidence concerns the gene AKT1 and preeclampsia.